Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 8.35 is 81% above its 5-year average of 4.61, near the high end of its 5-year range (0.00–11.81).
As of the fiscal period ended Tuesday, June 30, 2026. 46.43% above its 12-month average of 5.70.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 8.35.
QUICK RATIO (ACID-TEST)
8.35
QUICK RATIO (ACID-TEST) AVG TTM
5.70
QUICK RATIO (ACID-TEST) AVG 3Y
4.94
QUICK RATIO (ACID-TEST) AVG 5Y
4.61
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+46.43%
CURRENT VS 3Y AVG
+68.80%
CURRENT VS 5Y AVG
+80.94%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.20
median of 738 covered companies
CURRENT VS SECTOR MEDIAN
+161.24%
vs the sector median at left
Oculis Holding AG
Market Cap
$498.01M
Quick Ratio (Acid-Test)
8.35
TTM Avg
5.70
3Y Avg
4.94
5Y Avg
4.61
Market Cap
$502.82M
Quick Ratio (Acid-Test)
10.72
TTM Avg
8.23
3Y Avg
9.67
5Y Avg
9.58
Market Cap
$487.36M
Quick Ratio (Acid-Test)
2.64
TTM Avg
1.69
3Y Avg
1.64
5Y Avg
1.50
Market Cap
$509.02M
Quick Ratio (Acid-Test)
2.38
TTM Avg
3.66
3Y Avg
6.23
5Y Avg
9.46
Market Cap
$519.25M
Quick Ratio (Acid-Test)
26.78
TTM Avg
15.83
3Y Avg
15.06
5Y Avg
15.09
Market Cap
$474.59M
Quick Ratio (Acid-Test)
1.07
TTM Avg
1.48
3Y Avg
1.43
5Y Avg
1.74
Market Cap
$472.33M
Quick Ratio (Acid-Test)
121.97
TTM Avg
23.71
3Y Avg
19.95
5Y Avg
19.50
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oculis Holding AG (OCS) | $498.01M | 8.35 | 5.70 | 4.94 | 4.61 |
| Allogene Therapeutics, Inc. (ALLO)vs › | $502.82M | 10.72 | 8.23 | 9.67 | 9.58 |
| Evolus, Inc. (EOLS)vs › | $496.87M | 1.28 | 1.88 | 1.90 | 1.89 |
| Puma Biotechnology, Inc. (PBYI)vs › | $487.36M | 2.64 | 1.69 | 1.64 | 1.50 |
| 908 Devices Inc. (MASS)vs › | $509.02M | 2.38 | 3.66 | 6.23 | 9.46 |
| Arvinas, Inc. (ARVN)vs › | $479.39M | 7.91 | 4.78 | 4.69 | 6.49 |
| Altimmune, Inc. (ALT)vs › | $519.25M | 26.78 | 15.83 | 15.06 | 15.09 |
| Cerus Corporation (CERS)vs › | $474.59M | 1.07 | 1.48 | 1.43 | 1.74 |
| Bright Minds Biosciences Inc. (DRUG)vs › | $472.33M | 121.97 | 23.71 | 19.95 | 19.50 |
| Crescent Biopharma, Inc. (CBIO)vs › | $520.39M | 9.66 | 5.09 | 5.58 | 6.85 |
Quick Ratio
8.35
Excludes inventory
Current Ratio
8.35
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 8.35 |
| 2026-03-31 | 5.18 |
| 2025-12-31 | 5.96 |
| 2025-09-30 | 4.47 |
| 2025-06-30 | 4.55 |
| 2025-03-31 | 4.79 |
| 2024-12-31 | 2.37 |
| 2024-09-30 | 4.02 |
| 2024-06-30 | 5.27 |
| 2024-03-31 | 4.71 |
| 2023-12-31 | 5.29 |
| 2023-09-30 | 5.21 |
| 2023-06-30 | 7.22 |
| 2023-03-31 | 0.00 |
| 2022-12-31 | 1.97 |
| 2022-09-30 | 3.91 |
| 2022-06-30 | 4.27 |
| 2022-03-31 | 0.00 |
| 2021-12-31 | 11.81 |
| 2021-09-30 | 0.00 |
